Infectious Diseases (except HIV/AIDS)

We couldn't get details of this article at this time:
10.1101/2022.03.23.22272804
We couldn't get details of this article at this time:
10.1101/2022.03.22.22272793
We couldn't get details of this article at this time:
10.1101/2022.03.22.22272758
The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial

This article has 73 authors:
1. Thuy P. Nguyen
2. Quyet Do
3. Lan T. Phan
4. Dang D. Anh
5. Hiep Khong
6. Thuong V. Nguyen
7. Luong V. Hoang
8. Duc V. Dinh
9. Hung N. Pham
10. Men V. Chu
11. Toan T. Nguyen
12. Quang D. Pham
13. Tri M. Le
14. Tuyen N.T. Trang
15. Thanh T. Dinh
16. Thuong V. Vo
17. Thao T. Vu
18. Quynh B.P. Nguyen
19. Vuong T. Phan
20. Luong V. Nguyen
21. Giang T. Nguyen
22. Phong M. Tran
23. Thuan D. Nghiem
24. Tien V. Tran
25. Tien G. Nguyen
26. Tuynh Q. Tran
27. Linh T. Nguyen
28. Anh T. Do
29. Dung D. Nguyen
30. Son A. Ho
31. Viet T. Nguyen
32. Dung T. Pham
33. Hieu B. Tran
34. Son T. Vu
35. Su X. Hoang
36. Trung M. Do
37. Xuan T. Nguyen
38. Giang Q. Le
39. Ton Tran
40. Thang M. Cao
41. Huy M. Dao
42. Thao T.T. Nguyen
43. Uyen Y Doan
44. Vy T.T. Le
45. Linh P. Tran
46. Ngoc M. Nguyen
47. Ngoc T. Nguyen
48. Hang T.T. Pham
49. Quan H. Nguyen
50. Hieu T. Nguyen
51. Hang L.K. Nguyen
52. Nguyen V. Trang
53. Anh T.L. Nguyen
54. Linh T. Nguyen
55. Anh P. Nguyen
56. Nhung T.H. Trinh
57. Ly T.K. Le
58. Van T. B. Tran
59. Mai T. N. Chu
60. My H. Phan
61. My H. Phan
62. Hoa T. H. Nguyen
63. Vinh T. Tran
64. Mai T.N. Tran
65. Truc T.T. Nguyen
66. Phat T. Ha
67. Hieu T. Huynh
68. Khanh D. Nguyen
69. Nghia H.T. Duong
70. Ung T. Thuan
71. Chung C. Doan
72. May
73. Si M. Do
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 23, 2022Latest activity Mar 26, 2022
We couldn't get details of this article at this time:
10.1101/2022.03.21.22270828
Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis

This article has 16 authors:
1. Eva Stadler
2. Khai Li Chai
3. Timothy E Schlub
4. Deborah Cromer
5. Shanchita R Khan
6. Mark N Polizzotto
7. Stephen J Kent
8. Claire Beecher
9. Heath White
10. Tari Turner
11. Nicole Skoetz
12. Lise Estcourt
13. Zoe K McQuilten
14. Erica M Wood
15. David S Khoury
16. Miles P Davenport
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 1, 2023Latest activity Mar 25, 2022
We couldn't get details of this article at this time:
10.1101/2022.03.22.22272770
Immunogenic superiority and safety of Biological E CORBEVAX vaccine compared to COVISHIELD (ChAdOx1 nCoV-19) vaccine studied in a phase III, single blind, multicenter, randomized clinical trial

This article has 22 authors:
1. Subhash Thuluva
2. Vikram Paradkar
3. Kishore Turaga
4. Subbareddy Gunneri
5. Vijay Yerroju
6. Rammohan Reddy Mogulla
7. Venkata Suneetha Pothakamuri
8. Mahesh Kyasani
9. Senthilkumar Manoharan
10. Srikanth Adabala
11. Aditya Sri Javvadi
12. Guruprasad R Medigeshi
13. Janmejay Singh
14. Heena Shaman
15. Akshay Binayke
16. Aymaan Zaheer
17. Amit Awasrhi
18. Chandramani Singh
19. Venkateshwar Rao A
20. Indranil Basu
21. Akash Ashok Kumar Khobragade
22. Anil Kumar Pandey
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 22, 2022Latest activity Mar 25, 2022
Listening to Voices from African American Communities in the Southern States about COVID-19 Vaccine Information and Communication: A Qualitative Study

This article has 5 authors:
1. Ran Zhang
2. Shan Qiao
3. Brooke W. McKeever
4. Bankole Olatosi
5. Xiaoming Li
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 29, 2022Latest activity Mar 24, 2022
We couldn't get details of this article at this time:
10.1101/2022.03.19.22272637

Previous Page 182 of 716 Next

The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial

Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis

Immunogenic superiority and safety of Biological E CORBEVAX vaccine compared to COVISHIELD (ChAdOx1 nCoV-19) vaccine studied in a phase III, single blind, multicenter, randomized clinical trial

Listening to Voices from African American Communities in the Southern States about COVID-19 Vaccine Information and Communication: A Qualitative Study